-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cap-dependent-endonuclease-IN-25
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/2415788-71-3.gif)
| Category | Influenza Virus |
| CAS | 2415788-71-3 |
| Description | Cap-dependent endonuclease-IN-25 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-25 is a macrocyclic pyridotriazine derivative. Cap-dependent endonuclease-IN-25 has the potential for the research of viral infections caused by viruses belonging to the Orthomyxoviridae family. |
Product Information
| Synonyms | Cap-dependent endonuclease-IN-25|US11312727, Compound 4|BDBM552069|US11312727, Compound 13|HY-144068|CS-0375183|Synthesis of 4-hydroxy-16-phenyl-7,8,9,10,11,16-hexahydro-6,17-methanobenzo[k]pyrido[1,2-b][1,2,5]triazacyclotridecine-3,5-dione |
| Molecular Weight | 415.48 |
| Molecular Formula | C25H25N3O3 |
| Canonical SMILES | C1CCC2=CC=CC=C2C(N3CN(CC1)C(=O)C4=C(C(=O)C=CN43)O)C5=CC=CC=C5 |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 770 |
| Exact Mass | 415.18959167 |
| Target | Influenza Virus |
| XLogP3-AA | 4.9 |